Anthony Rosenberg

Business development and licensing

Anthony (Tony) Rosenberg served as Global Head M & A / licensing until February 2015 and in that role was responsible for Corporate M & A / Licensing across all Novartis divisions. This included execution of the Novartis Portfolio Transformation, comprising asset swaps/ divestments across several business sectors, which is currently seen as a unique set of transactions in the industry. Prior to this role Mr. Rosenberg was Global Head Business Development and Licensing, Novartis Pharma for 7 years. Earlier in his career in Novartis he was Head of Transplant /Immunology Global Business Unit  , after several marketing leadership roles.

Mr. Rosenberg has a B.Sc. (Hons) from University of Leicester, a M.Sc. Physiology from University of London.